Cargando…
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer
Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are members of the voltage‐gated cation channel family known to be expressed in the heart and central nervous system. Ivabradine, a small molecule HCN channel‐blocker, is FDA‐approved for clinical use as a heart rate‐reducing agent....
Autores principales: | Mok, Ka‐Chun, Tsoi, Ho, Man, Ellen PS, Leung, Man‐Hong, Chau, Ka Man, Wong, Lai‐San, Chan, Wing‐Lok, Chan, Sum‐Yin, Luk, Mai‐Yee, Chan, Jessie Y.W., Leung, Jackie K.M., Chan, Yolanda H.Y., Batalha, Sellma, Lau, Virginia, Siu, David C.W., Lee, Terence K.W., Gong, Chun, Khoo, Ui‐Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567035/ https://www.ncbi.nlm.nih.gov/pubmed/34841695 http://dx.doi.org/10.1002/ctm2.578 |
Ejemplares similares
-
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
por: Tsoi, Ho, et al.
Publicado: (2021) -
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2023) -
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022)